Thumbs down on Lilly, Innovent China trial for lung cancer drug Tyvyt, says FDA AdComm
10th February 2022 Uncategorised 0Thumbs down on Lilly, Innovent China trial for lung cancer drug Tyvyt, says FDA AdComm kdunleavy Thu, 02/10/2022 – 15:54 More: Thumbs down on Lilly, Innovent China trial for lung cancer drug Tyvyt, says FDA AdComm Source: fierce
read more